A significant breakthrough in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital tumor inhibitor protein is frequently lost in various types of tumors, leading https://thejillist.com/story12399722/mini-antibodies-reactivate-p53-the-potential-pathway-for-malignant-treatment